Introduction Neuromelanin-sensitive MR imaging (MRI) can visualize neuromelanin-containing neurons in the substantia nigra pars compacta (SNc), and its utility has been reported in the evaluation of parkinsonism. Conversely, dopamine transporter imaging by
I-N-v-fluoropropyl-2b-carbomethoxy3b-(4-iodophenyl)nortropane (FP-CIT) SPECT (DaTSCAN)
is now an established method for evaluating parkinsonism, detecting presynaptic dopamine neuronal dysfunction. Both methods can assist differentiating neurodegenerative and other forms of parkinsonism. However, to our knowledge, there have been no studies concerning a correlation between the two methods. The aim of this study was to assess the utility of neuromelanin-sensitive MRI for diagnosing parkinsonism by examining a correlation with DaTSCAN. Methods Twenty-three patients with parkinsonism who underwent both neuromelanin-sensitive MRI and DaTSCAN were included. We measured the neuromelanin-positive SNc region volume by manually contouring the high signal intensity region of the SNc on neuromelanin-sensitive MRI and measured the specific binding ratio (SBR) on DaTSCAN. The asymmetry index of neuromelanin-positive SNc volume and the asymmetry index of SBR were also calculated. Results The volume of the neuromelanin-positive SNc region showed significant correlation with specific binding ratio (SBR) (right P < .001, ρ = 0.78, left P < .001, ρ = 0.86). The asymmetry index of neuromelanin-positive SNc volume also
Introduction
Parkinsonism is divided into two groups, cases with or without nigrostriatal neurodegeneration. Pathologically, Parkinson disease, multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration are characterized by progressive neurodegeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc) and resulting dopamine deficiency in the striatum [1] [2] [3] [4] . Other forms of parkinsonism, such as drug-induced parkinsonism, vascular parkinsonism, and essential tremor, are not associated with a dopaminergic deficit.
Neuromelanin is a dark pigment that is located within certain catecholamine neurons of the human brain, such as the dopaminergic neurons of the SNc and the noradrenergic neurons of the locus ceruleus, and is thought to be formed as a by-product of the catecholamine metabolism cascade through enzymatic and/or oxidative polymerization [5, 6] . Several investigators have discovered that neuromelanin provides neuroprotection against toxic peroxynitrite and can bind iron to prevent iron-mediated toxic hydroxyl radical generation; thus, neuromelanin serves as an antioxidant to protect brain from oxidative stress [7, 8] . Recent studies suggested that a loose association between neuromelanin and iron may result in the increased production of free radicals and progressive degeneration of dopaminergic neurons of the SNc. Therefore, neuromelanin-containing neurons are particularly susceptible to neurodegeneration, and their depigmentation is the hallmark of neurodegenerative parkinsonism [9] .
Neuromelanin-sensitive MRI is a novel technique that can be used for the direct visualization of neuromelanincontaining neurons in the SNc and the locus ceruleus [10, 11] . Several investigators have reported that neuromelaninsensitive MRI could show a reduction in the signal intensity of the SNc in patients with neurodegenerative parkinsonism [12, 13] . On the other hand, molecular imaging techniques using single-photon emission computed tomography (SPECT) and positron emission tomography (PET) offer a variety of tools for diagnosing patients with parkinsonism [14] [15] [16] . SPECT of the nigrostriatal dopaminergic system and of the sympathetic innervation of the heart is widely used in this context [17, 18] . Imaging of dopamine transporter binding with 123 I-N-v-fluoropropyl-2b-carbomethoxy-3b-(4-iodophenyl)nortropane (FP-CIT) SPECT (DaTSCAN) is a sensitive method for detection of presynaptic dopamine neuronal dysfunction and has presently become an essential method for evaluating parkinsonism [19] .
Both methods can assist in the differentiation of neurodegenerative parkinsonism from other forms of parkinsonism that are not associated with dopaminergic deficit [19, 20] . However, after reviewing the literature, we have found no studies concerning a correlation between neuromelaninsensitive MRI and DaTSCAN.
The aim of this study is to assess the utility of neuromelanin-sensitive MRI for the diagnosis of parkinsonism by examining a correlation with DaTSCAN, which is an established method for evaluating parkinsonism.
Materials and methods

Patients
We investigated 23 patients (13 females and 10 males; mean age, 69 years; age range, 29−85 years) with parkinsonism. Results of both MRIs and DaTSCANs acquired within 2 months were retrospectively evaluated between May 2014 and December 2014. Seventeen of 23 patients had Parkinson disease, and the others were diagnosed with multiple system atrophy (n = 3), progressive supranuclear palsy (n = 1), spinocerebellar degeneration (n = 1), and essential tremor (n = 1). Patient characteristics are given in Table 1 .
Our hospital's institutional review board approved this retrospective study, and the requirement for written informed consent of the participants was waived by the review board due to the retrospective nature of the study.
Image acquisition
All MR images were acquired by means of a clinical 3T MR scanner (Discovery ™ MR750w, GE Healthcare, Milwaukee, WI). Axial images were acquired parallel to the anterior commissure-posterior commissure line. T1-weighted fast spin-echo sequences were applied to neuromelanin-sensitive MRI with the following parameters: TR/TE, 600/13 ms; echo train length, 2; section thickness, 2.5 mm with 2.5-mm intersection gaps; matrix size, 512 × 320; field of view (FOV), 220 mm; and acquisition time, 8.05 min. The scan covered the area from the upper border of the midbrain to the inferior border of the pons. We excluded other coexisting central nervous system disorders by use of axial T1-weighted image, T2-weighted image, fluid-attenuated inversion recovery (FLAIR) image, and diffusion-weighted image (DWI) of the entire brain according to the following standard protocol for adult 
Image analysis
On neuromelanin-sensitive MRI, the volume of the high signal intensity region of the SNc was measured in a blinded manner. The borders of the SNc neuromelanin-positive regions were manually traced in each slice on a liquid crystal display, and the areas were measured. The volume was calculated by multiplying the areas of the neuromelanin-positive SNc regions by the scanning thickness (2.5 mm) [13, 20] . In order to evaluate intrarater reproducibility, the process of the SNc volume measurement was performed three times on three different days. The average volume value of the three trials was used for the correlation analysis. The asymmetry index of neuromelanin-positive SNc volume was calculated using the following equations: On DaTSCAN, SPECT images were reconstructed with the iterative algorithm; the ordered subset expectation maximization and SBR were defined as the uptake ratio of (striatum − whole brain) / whole brain by using DaTView (Nihon Medi-Physics, Tokyo, Japan) [21] . The asymmetry index of SBR was also calculated using following equation: 
Statistical analysis
We analyzed the correlation between the neuromelaninpositive SNc volume and SBR using Spearman's rankorder correlation coefficient test. A correlation of the asymmetry indices between neuromelanin-positive SNc volume and SBR was analyzed in the same way. A P value of < .001 was considered statistically significant. Intrarater reproducibility was evaluated by an intraclass correlation coefficient based on the measured volumes of the three trials. An intraclass correlation coefficient value of >0.75 was considered Bgood to excellent.^Statistical analyses were performed using SPSS software version 23.0 (IBM, Chicago, IL).
Results
The neuromelanin-positive SNc volume and the SBR are given in Table 1 . The intraclass correlation coefficient of the three trials of SNc volume measurement was good to excellent (0.88).
The volume of the neuromelanin-positive SNc region on neuromelanin-sensitive MRI showed significant correlations with the SBR on DaTSCAN (right P < .001, ρ = 0.78, left P < .001, ρ = 0.86) (Fig. 1) . The asymmetry index of neuromelanin-positive SNc volume also showed significant correlations with the asymmetry index of SBR (P < .001, ρ = 0.73) (Fig. 2) .
On neuromelanin-sensitive MRI, a high signal intensity region of the SNc was widespread in the patient with essential tremor. On the other hand, the high signal intensity region of the SNc appeared to be decreased in the patients with Parkinson disease. On DaTSCAN images, uptake in the striatum in the patient with essential tremor was preserved, while it was decreased in the patients with Parkinson disease (Table 1, Fig. 3 ).
Discussion
This study aimed to establish the utility of neuromelaninsensitive MRI for the diagnosis of parkinsonism by examining a correlation with DaTSCAN. Our results suggest that the high signal intensity region of the SNc on neuromelanin-sensitive MRI reflects the function of the nigrostriatal dopaminergic system as well as the density of dopaminergic neurons. Neuromelanin can induce paramagnetic T1-shortening effects when combined with metals such as iron and copper [22, 23] . Sasaki et al. reported that neuromelanin-sensitive MRI could visualize neuromelanin-related contrast in the SNc as symmetrical, bandlike high signal intensity located around the posteromedial region of the cerebral peduncle using a 2-dimensional fast spin echo T1-weighted sequence with 3 Tesla MRI [10] . They also reported that their distribution obviously correlated with those of neuromelanin in gross specimens of the SNc, suggesting that the high signal intensity areas corresponded to neurons containing neuromelanin [24] . A previous study in our institution also showed that signal intensity of the SNc on postmortem neuromelaninsensitive MRI is related to the density of neuromelanincontaining neurons [25] . On the other hand, a loss of dopaminergic neurons in the SNc and of their nerve terminals in the striatum causes a corresponding reduction in striatal dopamine transporter binding [26] . Colloby et al. showed a significant correlation of striatal 123 I-FP-CIT uptake with the number of neuromelanin-containing neurons in the SNc neuropathologically [27] . We considered our results, which demonstrate a good correlation between neuromelanin-sensitive MRI and DaTSCAN, to be reflective of this neuropathological background.
The asymmetry index result raises the possibility of the utility of neuromelanin-sensitive MRI for evaluating the laterality of the nigrostriatal dopaminergic system function as well. The clinical features that best distinguish cases of Parkinson disease from other forms of parkinsonism with asymmetrical onset include bradykinesia, rigidity, and above all, resting tremor [28] . However, the differential diagnosis can be very difficult, even among movement disorder specialists, due to the great heterogeneity of clinical presentations; misdiagnosis is especially common during the early stages of disease. In contrast, DaTSCAN is a sensitive means to quantify striatal density of dopamine transporters, and dopamine transporter reduction significantly correlates in a linear way with the severity of rigidity and akinesia [29] . It has been reported that the laterality of FP-CIT uptake was also associated with the laterality of clinical symptoms in patients with Parkinson disease and contributed to the diagnosis of Parkinson disease at an early stage [30, 31] . Thus, the same utility can be expected from neuromelanin-sensitive MRI. Although the laterality of both the neuromelanin-positive SNc region on neuromelanin-sensitive MRI and the clinical symptoms have been suggested to correlate with the laterality of FP-CIT uptake on DaTSCAN, this does not necessarily mean a correlation of laterality between the neuromelaninpositive SNc region on MRI and clinical symptoms. Direct comparison will be needed.
Consequently, our results suggest that neuromelaninsensitive MRI is a useful diagnostic biomarker for parkinsonism. In recent years, other novel MRI techniques have been applied to parkinsonism to improve the understanding of pathophysiologic changes. In neurodegenerative parkinsonism, iron accumulation is seen in specific areas of the brain, but it is not clear whether this iron accumulation is a primary cause of the neurodegenerative process or a secondary response to neurodegeneration. Increased susceptibility associated with iron in the SNc in Parkinson disease has been reported using SWI [32] , R2* map [33] , and quantitative susceptibility mapping [34] . It has also been reported that significantly increased iron deposition was found using SWI in the entire putamen and pulvinar thalamus in multiple system atrophy with predominant parkinsonism [35] and in the putamen, red nucleus, and SNc in progressive supranuclear palsy [36] . These MRI techniques including neuromelaninsensitive MRI hold promise as additional diagnostic markers for parkinsonism. We believe our results will contribute to the establishment of advanced MRI techniques for the evaluation of parkinsonism.
Our study has some limitations. First, the slice thickness of the neuromelanin-sensitive MRI was relatively thick, thus there might have been measurement errors based on partialvolume effect. A further study will be needed using a 3-dimensional sequence for neuromelanin-sensitive MRI [37] . Second, the number of patients enrolled was small, and this study comprised very few patients with parkinsonism other than Parkinson disease, and no healthy subjects were included in the study. Third, our cases were clinically diagnosed but not autopsy-confirmed cases.
Conclusions
Decrease of the high signal intensity region of the SNc on neuromelanin-sensitive MRI would indicate damage to the nigrostriatal dopaminergic function as well as loss of dopaminergic neurons. We conclude that neuromelanin-sensitive MRI is a useful diagnostic biomarker for parkinsonism.
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